Alimera Sciences' ILUVIEN(R) Receives Marketing Authorization in Germany for the Treatment of Chronic Diabetic Macular Edema

Biopharmaceutical company Alimera announced it has received marketing authorization in Germany.... [more]

View complete Press Release article